Differential effects of novel ligands for 5-HT receptor subtypes on nonopioid defensive analgesia in male mice.

Abstract

The effects of a number of 5-HT receptor ligands were examined on nonopioid defensive analgesia in male DBA/2 mice. MDL 73005EF (0.05-1.0 mg/kg), a selective 5-HT1A receptor agonist, potently and dose-dependently inhibited the analgesic consequences of social defeat. CGS 12066B (0.5-10.0 mg/kg) and MK-212 (0.3-10.0 mg/kg), selective agonists for 5-HT1B and 5-HT1C sites, respectively, failed to influence this particular form of adaptive pain inhibition. Two 5-HT2/1C receptor antagonists, ritanserin (0.05-10.0 mg/kg) and ICI 169.369 (0.3-10.0 mg/kg), were also devoid of specific effects upon defensive analgesia. Both ritanserin and ICI 169,369 were found to have intrinsic analgetic efficacy and to induce behavioural changes indicative of increased defensiveness. These data, together with previous findings, confirm the specific involvement of 5-HT1A receptor mechanisms in the analgesic consequences of social defeat in male mice. Results are discussed in relation to the role of anxiety in adaptive pain inhibition.

• Authors: R J Rodgers, J K Shepherd, P Donát
• Journal: Neuroscience and biobehavioral reviews (Neurosci Biobehav Rev) Vol. 15 Issue 4 Pg. 489-95 ( 1991) ISSN: 0149-7634 [Print] United States
• PMID: 1792010 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Dioxins
• Pyrazines
• Quinolines
• Quinoxalines
• Receptors, Serotonin
• Serotonin Antagonists
• Spiro Compounds
• CGS 12066B
• Ritanserin
• binospirone mesylate
• 6-chloro-2-(1-piperazinyl)pyrazine
• 2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline

Topics

• Aggression (drug effects)
• Analgesia
• Animals
• Dioxins (pharmacology)
• Dose-Response Relationship, Drug
• Male
• Mice
• Mice, Inbred DBA
• Pyrazines (pharmacology)
• Quinolines (pharmacology)
• Quinoxalines (pharmacology)
• Reaction Time (drug effects)
• Receptors, Serotonin (drug effects)
• Ritanserin (pharmacology)
• Serotonin Antagonists (pharmacology)
• Spiro Compounds (pharmacology)